Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma

  • Authors:
    • Lin Zhu
    • Gang Qin
    • Lin Ye
    • Li‑Zhu Jiang
    • Tie‑Jun Zhou
    • Bo Luo
    • Tao‑Yu Wen
    • Ya‑Lan Liu
    • Hong‑Yan Chen
  • View Affiliations

  • Published online on: April 8, 2019     https://doi.org/10.3892/ol.2019.10226
  • Pages: 5699-5704
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Epithelial cell transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor and its expression is associated with the development of malignant tumor types. However, to the best of our knowledge, there is no information on the role of ECT2 in the development and progression of laryngeal squamous cell carcinoma (LSCC). The present study aimed at investigating the expression pattern and potential role of ECT2 in the development and progression of LSCC. The expression of ECT2 in 81 pairs of LSCC and adjacent non‑tumor tissues was characterized by immunohistochemistry and reverse transcription‑quantitative polymerase chain reaction. ECT2 expression was upregulated in LSCC tissues and associated significantly with poor differentiation, higher stages, lymph node metastasis and poor survival in the sample population. The relative expression levels of ECT2 mRNA transcripts were correlated with the intensity of anti‑ECT2 staining in 25 ECT2+LSCC specimens selected randomly. These results indicated that ECT2 expression was crucial for the progression of LSCC and may serve as a biomarker for the diagnosis and prognosis of LSCC.

References

1 

Ferlay J, Bray F, Pisani P and Parkin DM: GLOBOCAN 2000: Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC CancerBase No. 5. Lyon. (IARCPress). 2001.

2 

Ramroth H, Dietz A and Becher H: Interaction effects and population-attributable risks for smoking and alcohol on laryngeal cancer and its subsites. A case-control study from Germany. Methods Inf Med. 43:499–504. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Shangina O, Brennan P, Szeszenia-Dabrowska N, Mates D, Fabiánová E, Fletcher T, t'Mannetje A, Boffetta P and Zaridze D: Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe. Am J Epidemiol. 164:367–375. 2006. View Article : Google Scholar : PubMed/NCBI

4 

Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, Negri E, Pasche C, Vaccarella S, Barzan L, et al: Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 13:957–964. 2002. View Article : Google Scholar : PubMed/NCBI

5 

Becher H, Ramroth H, Ahrens W, Risch A, Schmezer P and Dietz A: Occupation, exposure to polycyclic aromatic hydrocarbons and laryngeal cancer risk. Int J Cancer. 116:451–457. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Ramroth H, Dietz A, Ahrens W and Becher H: Occupational wood dust exposure and the risk of laryngeal cancer: a population based case-control study in Germany. Am J Ind Med. 51:648–655. 2008. View Article : Google Scholar : PubMed/NCBI

7 

Nachalon Y, Cohen O, Alkan U, Shvero J and Popovtzer A: Characteristics and outcome of laryngeal squamous cell carcinoma in young adults. Oncol Lett. 13:1393–1397. 2017. View Article : Google Scholar : PubMed/NCBI

8 

Scoumanne A and Chen X: The epithelial cell transforming sequence 2, a guanine nucleotide exchange factor for Rho GTPases, is repressed by p53 via protein methyltransferases and is required for G1-S transition. Cancer Res. 66:6271–6279. 2006. View Article : Google Scholar : PubMed/NCBI

9 

Miki T, Smith CL, Long JE, Eva A and Fleming TP: Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature. 362:462–465. 1993. View Article : Google Scholar : PubMed/NCBI

10 

Yüce O, Piekny A and Glotzer M: An ECT2-centralspindlin complex regulates the localization and function of RhoA. J Cell Biol. 170:571–582. 2005. View Article : Google Scholar : PubMed/NCBI

11 

Tatsumoto T, Xie X, Blumenthal R, Okamoto I and Miki T: Human ECT2 is an exchange factor for Rho GTPases, phosphorylated in G2/M phases, and involved in cytokinesis. J Cell Biol. 147:921–928. 1999. View Article : Google Scholar : PubMed/NCBI

12 

Sano M, Genkai N, Yajima N, Tsuchiya N, Homma J, Tanaka R, Miki T and Yamanaka R: Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients. Oncol Rep. 16:1093–1098. 2006.PubMed/NCBI

13 

Saito S, Liu XF, Kamijo K, Raziuddin R, Tatsumoto T, Okamoto I, Chen X, Lee CC, Lorenzi MV, Ohara N, et al: Deregulation and mislocalization of the cytokinesis regulator ECT2 activate the Rho signaling pathways leading to malignant transformation. J Biol Chem. 279:7169–7179. 2004. View Article : Google Scholar : PubMed/NCBI

14 

Matthews HK, Delabre U, Rohn JL, Guck J, Kunda P and Baum B: Changes in Ect2 localization couple actomyosin-dependent cell shape changes to mitotic progression. Dev Cell. 23:371–383. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Luo Y, Qin SL, Mu YF, Wang ZS, Zhong M and Bian ZQ: Elevated expression of ECT2 predicts unfavorable prognosis in patients with colorectal cancer. Biomed Pharmacother. 73:135–139. 2015. View Article : Google Scholar : PubMed/NCBI

16 

Murata Y, Minami Y, Iwakawa R, Yokota J, Usui S, Tsuta K, Shiraishi K, Sakashita S, Satomi K, Iijima T, et al: ECT2 amplification and overexpression as a new prognostic biomarker for early-stage lung adenocarcinoma. Cancer Sci. 105:490–497. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Patel SG and Shah JP: TNM staging of cancers of the head and neck: Striving for uniformity among diversity. CA Cancer J Clin. 55:242–258; quiz 261–262, 264. 2005. View Article : Google Scholar : PubMed/NCBI

18 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

19 

Wang HB, Yan HC and Liu Y: Clinical significance of ECT2 expression in tissue and serum of gastric cancer patients. Clin Transl Oncol. 18:735–742. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Guo Z, Chen X, Du T, Zhu D, Lai Y, Dong W, Wu W, Lin C, Liu L and Huang H: Elevated levels of epithelial cell transforming sequence 2 predicts poor prognosis for prostate cancer. Med Oncol. 34:132017. View Article : Google Scholar : PubMed/NCBI

21 

Rizzardi AE, Johnson AT, Vogel RI, Pambuccian SE, Henriksen J, Skubitz AP, Metzger GJ and Schmechel SC: Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol. 7:422012. View Article : Google Scholar : PubMed/NCBI

22 

Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: GLOBOCAN 2012 v1.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer. (Lyon, France). 2013.

23 

Justilien V, Jameison L, Der CJ, Rossman KL and Fields AP: Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. J Biol Chem. 286:8149–8157. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Justilien V and Fields AP: Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene. 28:3597–3607. 2009. View Article : Google Scholar : PubMed/NCBI

25 

Vergote I, De Brabanter J, Fyles A, Bertelsen K, Einhorn N, Sevelda P, Gore ME, Kaern J, Verrelst H, Sjövall K, et al: Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet. 357:176–182. 2001. View Article : Google Scholar : PubMed/NCBI

26 

Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H and Celis JE: Proteome profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res. 57:4111–4117. 1997.PubMed/NCBI

27 

Pollina L, Pacini F, Fontanini G, Vignati S, Bevilacqua G and Basolo F: bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas. Br J Cancer. 73:139–143. 1996. View Article : Google Scholar : PubMed/NCBI

28 

Elston CW and Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology. 19:403–410. 1991. View Article : Google Scholar : PubMed/NCBI

29 

Cook DR, Rossman KL and Der CJ: Rho guanine nucleotide exchange factors: Regulators of Rho GTPase activity in development and disease. Oncogene. 33:4021–4035. 2014. View Article : Google Scholar : PubMed/NCBI

30 

Mack NA and Georgiou M: The interdependence of the Rho GTPases and apicobasal cell polarity. Small GTPases. 5:102014. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zhu, L., Qin, G., Ye, L., Jiang, L., Zhou, T., Luo, B. ... Chen, H. (2019). Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma. Oncology Letters, 17, 5699-5704. https://doi.org/10.3892/ol.2019.10226
MLA
Zhu, L., Qin, G., Ye, L., Jiang, L., Zhou, T., Luo, B., Wen, T., Liu, Y., Chen, H."Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma". Oncology Letters 17.6 (2019): 5699-5704.
Chicago
Zhu, L., Qin, G., Ye, L., Jiang, L., Zhou, T., Luo, B., Wen, T., Liu, Y., Chen, H."Epithelial cell transforming sequence 2 expression is associated with the progression of laryngeal squamous cell carcinoma". Oncology Letters 17, no. 6 (2019): 5699-5704. https://doi.org/10.3892/ol.2019.10226